University of Patras
Ο ρόλος του TGF-B-R και των πρωτεϊνών Smad και Ski σε ασθενείς με καρκίνο μαστού και συσχέτιση με την επιβίωση
Abstract
dc:descriptionIntroduction: Transforming Growth Factor beta signaling pathway is thoroughly studied in a series of diseases and this molecule has been proved to act either as an oncogene or as a tumor suppressor molecule in human carcinogenesis. Recently, the Smad proteins' family has been identified as TGF-beta's intracellular substrates, which transfer the signal in the cell's nucleus. A lot of molecules have also been found to act as co-repressors or co-activators in this procedure. Ski protein is one of the most well-known Smad proteins' co-repressors. On the other hand, breast cancer is one of the most common cancers in women, and the discovery of new predictive factors, especially at early stages of the disease is very challenging. Objective: The purpose of the present study was the investigation of the expression of TGF-β receptor, as well as the expression of Smad2/3 and Ski protein in T1, T2, -node negative breast cancer specimens and the potent correlation of their expression with several clinicopathological parameters. The most important of these were tumor Grade, hormone receptors' positivity as well as the patients' outcome (blood - borne metastases or death of their disease). Materials and methods: 146 breast cancer specimens were used, among which 21 in situ and 125 invasive. The proteins' expression was studied using immunohistochemistry (biotin-streptabidin indirect method). The evaluation of the immunopositivity was not only qualitative (negative versus positive) but also quantitative (negative, weakly positive and strongly positive) depending on the number of positive tumor cells and the staining's intensity). The statistical analysis of the results was implemented using the SPSS13 for windows. Results: TGF-β receptor's expression was inversely correlated with tumor Grade as well as with the presence of blood- borne metastases and patients' death. The expression of Smad2/3 protein was proved to be an independent prognostic factor in Grade I invasive carcinomas while loss of Smad4 expression was strongly correlated with poor patients' outcome in ER (Estrogen Receptor)-positive tumors. All three proteins' positivity had statistically significant correlation with each other Ski proteins' expression (qualitative and quantitative) was strongly correlated with tumors' Grade, with the presence of distant metastases and was also proved to be an independent prognostic factor for patients' survival. Another important observation was the intracellular translocation of Ski’s expression from the nucleus to the cytoplasm of tumor cells in high Grade tumors and the strong relationship between cytoplasmic Ski expression and loss of expression of Smad2/3. Conclusions: Smad proteins seem to be TGF-beta intracellular substrates and, according to our results, play a tumor suppressor role in mammary gland tumorigenesis. On the other hand, Ski protein acts as an oncogene in breast carcinogenesis procedure modulating the TGF-beta pathways' effect. All the studied proteins are potent targets of a pioneering molecular therapy.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Koumoundourou, Dimitra
- Κουμουνδούρου, Δήμητρα
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/25752